#cardiology--Biome Analytics, the leading cardiovascular performance management company, announced today that Brian Maher, MPH, has been appointed as the new Vice President of Business Development. Br...
SAN FRANCISCO: #cardiology--Biome Analytics, the leading cardiovascular performance management company, announced today that Brian Maher, MPH, has been appointed as the new Vice President of Business Development.
Brian brings a wealth of experience to Biome Analytics with 20 years of consultative support to hundreds of health care systems and industry partners. He joins Biome after nearly a decade with Abbott, where he assisted in the commercialization of Abbott’s Digital Health Solutions division and products associated with EMR integration and optimization. Previously, he served as the program director for The Advisory Board Company’s Cardiovascular Roundtable, which produced strategic guidance and disseminated best practices to over 1,200 heart and vascular programs.
“Brian Maher’s appointment is a significant step forward in our mission to revolutionize cardiovascular care. His strategic acumen, knowledge of the market, and ability to help solve complex problems will help fuel our growth ambitions,” said Stuart Jacobson, Biome’s Chief Executive Officer.
Stephen Hiscott, Chief Growth Officer, commented, “We are delighted to welcome Brian to the Biome team. His deep understanding of the healthcare landscape and thought leadership will undoubtedly propel Biome to new heights, enabling us to better serve our partners and ultimately improve patient outcomes.”
“Today’s cardiovascular program leaders face a challenging dilemma – how to achieve profitable growth while delivering superior clinical outcomes at the lowest expense possible. I’m thrilled to join Biome, as it is abundantly clear that Biome has both the technology, services, and vision drive targeted, transformative change for as many health care systems as possible,” said Brian Maher, MPH, Vice President of Business Development.
About Biome Analytics
Biome (www.biome.io) is the leading cardiovascular performance company dedicated to helping physicians and health systems deliver the best care to the most patients at the lowest cost. We partner with ambitious enterprise heart centers and cardiovascular teams looking to achieve superior clinical and financial performance. Clients rely on our proprietary machine learning, human-enabled technology, and our community-driven knowledge network to activate their data assets, engage physicians, and accelerate performance improvement. Within days of onboarding, clients gain actionable insights with minimal impact on IT resources.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
On Monday, July 14, 2025 at 10:00 a.m. Eastern Time, Mastercard Incorporated (NYSE: MA) will host a session to explore Mastercard’s recent announcements…
#3PL--Wave Function™, a New Bedford, MA-based founding partnership company, has invested in Packsmith.ai, a Los Angeles-based, AI-driven third-party logistics…
#AI--EvenUp, the highest-funded AI technology company serving personal injury law firms, has officially opened its new headquarters at 353 Sacramento…
Amazon announced today that Prime Day 2025 was its biggest Prime Day event ever and that customers saved billions on deals across more than 35 product…